Catheter Precision (VTAK) Return on Capital Employed (2018 - 2026)
Catheter Precision's (VTAK) quarterly Return on Capital Employed came in at 346.78% in Q1 2026, down 29180.0% year-on-year from N/an in Q1 2025, and down 174.88% on a QoQ basis from 126.16% in Q4 2025.
Catheter Precision (VTAK) Return on Capital Employed (2018 - 2026) Analysis & Trends
Catheter Precision (VTAK) has 9 years of Return on Capital Employed data on file, last reported at 346.78% in Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 29180.0% year-over-year to 346.78% in Q1 2026; TTM through Mar 2026 was 346.78%, a 29180.0% decrease from a year earlier, with the FY2025 full-year figure at 118.06%, down 7646.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 346.78%, down from 126.16% in the prior quarter.
- Over the last five years, Return on Capital Employed for VTAK reached as high as 52.73% in Q1 2024 and fell as low as 346.78% in Q1 2026.
- Historically, Return on Capital Employed has averaged 203.38% across 5 years, with a median of 203.27% in 2023.
- Across the five-year window, Return on Capital Employed soared 25891 bps in 2024 and slumped 29180 bps in 2026, its largest moves.
- Year by year, Return on Capital Employed stood at 281.5% in 2022, then increased by 5 bps to 266.33% in 2023, then surged by 80 bps to 52.73% in 2024, then sank by 139 bps to 126.16% in 2025, then sank by 175 bps to 346.78% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 346.78% in Q1 2026, 126.16% in Q4 2025, and 191.98% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Catheter Precision | 0.80 | -811,999.20 | 390,000.00 | -346.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -346.78% |
| Dec 31, 2025 | -126.16% |
| Sep 30, 2025 | -191.98% |
| Jun 30, 2025 | -181.39% |
| Mar 31, 2025 | -54.97% |
| Mar 31, 2024 | -52.73% |
| Dec 31, 2023 | -266.33% |
| Sep 30, 2023 | -260.28% |
| Jun 30, 2023 | -214.56% |
| Mar 31, 2023 | -311.64% |
| Dec 31, 2022 | -281.50% |
| Mar 31, 2022 | -152.21% |
| Dec 31, 2021 | -159.44% |
| Sep 30, 2021 | -128.77% |
| Jun 30, 2021 | -144.71% |
| Mar 31, 2021 | -148.56% |
| Dec 31, 2020 | -116.15% |
| Sep 30, 2020 | -103.58% |
| Jun 30, 2020 | -150.15% |
| Mar 31, 2020 | -147.99% |